An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis

Atiq, Omair, Tiro, Jasmin, Yopp, Adam C., Muffler, Adam, Marrero, Jorge A., Parikh, Neehar D., Murphy, Caitlin, McCallister, Katharine, Singal, Amit G.·2017·Hepatology
DOI 10.1002/hep.28895

Cited by (266)

Items 201–266 of 266

  1. Abbreviated gadoxetic acid–enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol
    Hyo Jung Park, Jonggi Choi, Dong Wook Kim, Sang Hyun Choi, Won‐Mook Choi, Sung Won Chung, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Y-J Lim et al. · 2025 · Hepatology Communications
  2. Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis
    Nutcha Pinjaroen, Wirichada Pan Ngum, Kittiyod Poovorawan, David Wastlund, Fabian Mueller, Peng Lu, Rebecca Sim Shu Yu, Pisit Tangkijvanich · 2026 · PLoS ONE
  3. Surveillance of patients at risk of liver cancer: Expert opinions
    Terry Cheuk‐Fung Yip, Hamish A. Innes, Grace Lai‐Hung Wong, Peter Jepsen · 2026 · Journal of Hepatology
  4. Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
    Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang · 2024 · OncoTargets and Therapy
  5. Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
    Emily Truong, Cheng Han, Mark Dhinesh Muthiah, Mazen Noureddin · 2023 · Current Hepatology Reports
  6. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents
    Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Aly Abdelkhalek Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief et al. · 2023 · Frontiers in Virology
  7. CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data
    Amit G. Singal · 2017 · The American Journal of Gastroenterology
  8. Reply
    Omair Atiq, Jasmin A. Tiro, Adam Charles Yopp, Adam Muffler, Jorge A. Marrero, Neehar D. Parikh, Caitlin C. Murphy, Katharine McCallister, Amit G. Singal · 2017 · Hepatology
  9. Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study
    Tami Gurley, Rubén Hernáez, Vanessa Cerda, Tynaje Thomas, Manasa Narasimman, Sukul Mittal, Mohammed Al-Hasan, Darine Daher, Amit G. Singal · 2025 · EClinicalMedicine
  10. Should Contrast-Enhanced Computed Tomography and/or Magnetic Resonance Imaging Play a Routine Role in Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis?
    Jorge A. Marrero · 2025 · Springer eBooks
  11. MRI management of focal liver lesions: what a beginner cannot fail to know
    Vincenza Granata, Roberta Fusco, Igino Simonetti, Maria Giovanna Riga, Giuseppe Pellegrino, Serena Carriero, Michele Ahmed Antonio Karaboue, Gianpaolo Carrafiello, Antonella Petrillo, Francesco Izzo · 2025 · Frontiers in Oncology
  12. Integrative Analysis of Fucosylated Tetra Glycoforms in Hepatocellular Carcinoma: A NanoLC-PRM-MS/MS and Machine Learning Approach
    Chithravel Vadivalagan, Jie Zhang, Jianliang Dai, Suyu Liu, Amit G. Singal, Kevin Bass, Neehar D. Parikh, David M. Lubman · 2025 · Journal of Proteome Research
  13. Construction and validation of NSMC-ASIL, a predictive model for risk assessment of malignant hepatic nodules.
    Jinmei Li, Yue Xu, Hua Liu, Bin Guo, Xiaolan Guo, Yushan Li, Xingliang Jiang, Qiang Wang · 2022 · PubMed Central
  14. Current updates in HCC screening and treatment
    Thomas M. Hunold, Anjana A Pillai · 2023 · Clinical Liver Disease
  15. Molecular profiling in the management of hepatocellular carcinoma
    Nadine Soliman, Ashish Saharia, Maen Abdelrahim, Ashton Anthony Connor · 2023 · Current Opinion in Organ Transplantation
  16. Hepatocellular Carcinoma from a Hepatologist's Perspective
    Giovanni A. Roldan, Jacquelin Blomker, Elizabeth S. Aby · 2023 · Seminars in Interventional Radiology
  17. Five‐Gene Expression Formula Accurately Detects Hepatocellular Carcinoma Tumors
    Aram Ansary Ogholbake, Qiang Shawn Cheng · 2025 · Biotechnology Journal
  18. Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes
    David T. Fetzer · 2021 · American Journal of Roentgenology
  19. When to Stop Screening—Liver Cancer
    Tamar Hamosh Taddei, Janice H. Jou · 2022 · The American Journal of Gastroenterology
  20. Is Screening for Hepatocellular Carcinoma Effective?
    Rachel M. Lee, Maria Citarella Russell · 2023 · Advances in Surgery
  21. The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis
    Pierre Nahon, Richard Layese, Nathalie Ganne‐Carrié, Cécile Moins, G. Nkontchou, Cendrine Chaffaut, Maxime Ronot, Étienne Audureau, Isabelle Durand‐Zaleski, Pierre-André Natella et al. · 2023 · Hepatology
  22. Hepatocellular carcinoma: Where are we in 2018?
    William C. Chapman, Kevin Korenblat, Kathryn Jane Fowler, Nael E. A. Saad, Adeel S. Khan, Vijay Subramanian, Maria B. Majella Doyle, Leigh Anne Dageforde, Benjamin R. Tan, Patrick M. Grierson et al. · 2018 · Current Problems in Surgery
  23. Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century - authors' reply
    Okeefe L. Simmons, David T. Fetzer, Takeshi Yokoo, Jorge A. Marrero, Adam Charles Yopp, Neehar D. Parikh, Travis G. Browning, Amit G. Singal · 2017 · Alimentary Pharmacology & Therapeutics
  24. A new tool for estimating liver cancer risk after a hepatitis C virus cure
    Hamish A. Innes, William Lucien Irving · 2020 · HepatoBiliary Surgery and Nutrition
  25. Hepatocellular carcinoma surveillance in cirrhotic patients: Beyond guidelines
    Mohammed Omar Khalifa Elsayed · 2023 · Gastroenterology and Functional Medicine
  26. Can the detection of serum glutathione reductase serve as an effective complement to traditional tumor biomarkers in clinical laboratory medicine for patients with hepatocellular carcinoma?
    Qingzhu Zheng, Siyan Chen, Jiamiao Weng, Hua Huang, Xiaohong Xu, Yingping Cao · 2025 · BMC Cancer
  27. Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multisite Conjoint Analysis
    Karissa D. Kao, Jonathan P. Troost, Ju Dong Yang, Reena J. Salgia, Sean A. Woolen, Neil J. Mehta, Maarouf A. Hoteit, Prasun K. Jalal, Karim Seif El Dahan, Darine Daher et al. · 2026 · The American Journal of Gastroenterology
  28. Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease
    Luís Neves da Silva, Elisabete Cerqueira, Joana Freitas Ribeiro, Pedro Simões, Sofia Raquel Guimarães Almeida Miguelote, Ana Sofia Maciel Campos da Silva, Beatriz Fernandes, Catarina Melita, Joana Vieira, Sara Pereira et al. · 2026 · Annals of Hepatology
  29. Hepatocellular carcinoma surveillance in Europe: challenges and lessons from global practice
    Maria Qurashi, Marı́a Buti, Grace Lai‐Hung Wong, Huma I Qureshi, Masatoshi Kudo, Tawesak Tanwandee, Chien‐Jen Chen, Ashraf Omar Abdelaziz, Mohamed AbdAllah, Jessica A. Howell et al. · 2026 · The Lancet Regional Health - Europe
  30. Theranostic and precision medicine for the diagnosis of hepatocellular carcinoma
    Rafael Miret, Amir Riaz, Sikandar G. Khan, Asad Ur Rahman · 2022 · Elsevier eBooks
  31. National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022
    Moisés Cukier, José M. Cabada-Lee, Jorge David Mendez-Rios, Rafaél Arauz, Erik Araúz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz et al. · 2022 · Cancer Studies and Molecular Medicine - Open Journal
  32. Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia
    Samuel Hui, Andrew Nguyen, Suong T. T. Le, Anouk T Dev, Sally Bell · 2024 · Internal Medicine Journal
  33. THE IMPACT OF WORK-LIFE BALANCE ON TURNOVER INTENTIONS: EXPLORING THE MEDIATING ROLE OF JOB SATISFACTION
    Reni Handayani, Roni Faslah, Maulana Amirul Adha · 2024 · Jurnal Pendidikan Ekonomi Perkantoran dan Akuntansi
  34. Personalizing Colon Cancer Screening: Role of Age and Comorbid Conditions
    Melissa Magrath, Edward Yang, Amit G. Singal · 2017 · Current Colorectal Cancer Reports
  35. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps
    Alan L. Hutchison, Anjana A Pillai · 2021 · Current Opinion in Organ Transplantation
  36. Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients
    Emily Truong, Mazen Noureddin · 2022 · Hepatoma Research
  37. Emphasis on harms of hepatocellular carcinoma surveillance: Just pretending innocence after taking advantage?
    Zheng Wang, Jun Shu Han, Han Zhang, Mengchao Wu, Tian Yang · 2017 · Hepatology
  38. Is there a real survival benefit of surveillance for hepatocellular carcinoma in cirrhotic patients?
    Massimo Colombo, Ana Lleò · 2019 · HepatoBiliary Surgery and Nutrition
  39. Reply to: “Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead”
    Raghuraman Soundararajan, Pankaj C. Gupta · 2021 · Journal of Hepatology
  40. Unscheduled screening tests cannot be termed as surveillance
    Xuejun Xu, Huaizhi Wang, Ping Bie · 2017 · Hepatology
  41. Ultrasound Screening and Surveillance in Hepatocellular Carcinoma
    Emily Pang, Alison C. Harris · 2019 · Current Radiology Reports
  42. Reply
    Amit G. Singal · 2019 · Gastroenterology
  43. Screening for hepatocellular carcinoma in viral liver disease: any new biomarkers on the horizon?
    Saroja D. Bangaru, Jorge A. Marrero, Amit G. Singal · 2020
  44. Reply
    Nicole J. Kim, George N. Ioannou · 2020 · Clinical Gastroenterology and Hepatology
  45. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East
    Said A. Al‐Busafi, Khalid M. Al-Naamani · 2021 · Springer eBooks
  46. Reply
    Amit G. Singal, Neehar D. Parikh · 2022 · Hepatology
  47. Reply
    Nicole E. Rich, Amit G. Singal · 2018 · Gastroenterology
  48. Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients
    Azza Abdel Rahman Saab, Emad Ahmed Awad, Tarek Mohammed Youssef, MohamedO Aly · 2020 · The Egyptian Journal of Laboratory Medicine
  49. Interdisciplinary Approach in Hepatobiliary Cancers
    Vahid Mansouri, Nima Rezaei · 2022 · Interdisciplinary cancer research
  50. A CpG-based prediction model for the diagnosis of hepatocellular carcinoma patients
    Biyuan Luo, Ning Zhou, Zui Chen, Xianling Liu · 2023 · Research Square
  51. Role of human body fluid biomarkers in liver cancer: A systematic review
    Dahrii Paul, Vigneshwar Suriya Prakash Sinnarasan, Rajesh Das, Dinakara Rao Ampasala, Amouda Venkatesan · 2023 · Elsevier eBooks
  52. Data from Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
    Mohammad Azharul Karim, Amit G. Singal, Hye‐Chung Kum, Yi‐Te Lee, Sulki Park, Nicole E. Rich, Mazen Noureddin, Ju Dong Yang · 2023
  53. Evaluation of Hepatocellular Carcinoma Surveillance with Contrast-enhanced MRI in a High-Risk Western European Cohort
    Federico Fiduzi, François E.J.A. Willemssen, Céline van de Braak, Quido G. de Lussanet, Jan N.M. IJzermans, Daniël Bos, Robert Auke de Man, Roy S. Dwarkasing · 2024 · Current Problems in Diagnostic Radiology
  54. Raising the Bar: Is Hepatocellular Carcinoma Surveillance Warranted for Patients With Alcohol-Associated Cirrhosis?
    Andrew M. Moon · 2024 · The American Journal of Gastroenterology
  55. Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs
    Man-Lei Jiang, Fei Xu, Jinlong Li, Jia-Yu Luo, Jianda Hu, Xi Zeng · 2025 · World Journal of Hepatology
  56. Should Biomarkers, Such as Alpha Fetoprotein, Play a Routine Role in Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis?
    Ashwin Rao, Amit G. Singal · 2025 · Springer eBooks
  57. Should a Randomized Controlled Trial of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis Be Performed?
    Ian A.C. Rowe · 2025 · Springer eBooks
  58. Additional file 1 of Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients
    Hou, Yixin, Hao Yu, Zhang, Qun, Yang, Yuying, Liu, Xiaoli, Wang, Xianbo, Jiang, Yuyong · 2023 · Figshare
  59. Psychosocial impact of false-positive surveillance for hepatocellular carcinoma: a qualitative study
    Samuel Hui, Suong Le, Anouk T Dev, Sally Bell · 2026 · Supportive Care in Cancer
  60. Net benefit of surveillance varies by hepatocellular carcinoma risk in patients with cirrhosis
    Akash Patel, Elena I. Gavrila, Sruthi Yekkaluri, Yujin Hoshida, Rubén Hernáez, Amit G. Singal · 2026 · JHEP Reports
  61. Establishment of a Predictive model for primary liver cancer based on extracellular vesicle microRNA and serum biomarkers
    Jingmin Chang, Yawen Xu, Xiaoli Liu, Chenmin Zhang, Hongjiang Li, Wenfang Yuan, Haojie Zheng, Fumin Feng, Jing Zhang, Dai Erhei · 2026 · Research Square
  62. A prospective cohort validation study of a multivariable algorithm ASAP for risk stratification of hepatocellular carcinoma surveillance
    Wei Lun Liou, Siyu Tan, Laurel Jackson, Jason Pik-Eu Chang, Thinesh Lee Krishnamoorthy, Claire Chen, Chin‐Pin Yeo, C H Tan · 2026 · Annals of Hepatology
  63. FROM BIOMARKERS TO PRECISION SURVEILLANCE: A SOCIO-TECHNICAL REVIEW OF NON-INVASIVE HEPATOCELLULAR CARCINOMA SCREENING IN CIRRHOSIS
    Kamil Chudzicki, Michał Babicz, Oliwer Muller, Jagoda Pałubska, Katarzyna Rosa, Agata Słoma, Anna Szot, Dominik Szydełko, Martyna Szymczyk, Paweł Żurek · 2026 · International Journal of Innovative Technologies in Social Science
  64. A bibliometric analysis of hepatocellular carcinoma screening in high risk populations
    Chengdian Lan, Dan-Lan Lian, Cui-Ling Huang · 2026 · Discover Oncology
  65. Performance of Cobas e801 for detection of serum prothrombin induced by vitamin K absence-II in hepatocellular carcinoma: A comparative study
    Hongkyung Kim, Jinho Heo, Sinyoung Kim, Younhee Park · 2026 · Heliyon
  66. In silico integration of pan-cancer transcriptomics and curated blood-urine secretome data using explainable machine learning identifies APOF, C9, HP, and OIT3 as biomarker candidates for liver cancer
    Dahrii Paul, Vigneshwar Suriya Prakash Sinnarasan, Rajesh Das, Md Mujibur Rahman Sheikh, Santhosh Manickannan, Amouda Venkatesan · 2026 · In Silico Research in Biomedicine